NCT05815732

Brief Summary

The main objective of this clinical trial is to test the effects of the personalized intervention based on physical exercise, on clinical variables and circulating markers, in a population of employees of the University of Milan (UMilan). The HEBE study will include two phases: PHASE 1: All UMilan employees will be asked to voluntarily complete an anonymous online questionnaire, in order to gather information about their lifestyle (physical activity, diet, cigarette smoking, etc) (zero time: T0); at the end of the compilation, indications on how to improve the lifestyle will be provided. These indications will also be present and available for consultation in a special section of the site on the "HEBE" site, with UMilan domain (www.hebe.unimi.it). After 6 months, all UMilan employees will receive a second invitation to voluntarily complete the same questionnaire, in order to evaluate any changes, in terms of lifestyle improvement (time one: T1). PHASE 2: 100 eligible subjects who have expressed their availability in the initial questionnaire, will be identified to undergo a lifestyle improvement protocol based mainly on the prescription of a personalized exercise program, which will define modalities, intensity, duration, frequency and progression of the exercise. For each subject, at T0 and T1 (after 6 months), biological samples will be collected (blood, urine, saliva and nasal swab), which will be used to: i) set up a biobank shared by the members of the HEBE consortium; ii) identify biomarkers able to monitor the effect of physical exercise on the characteristics of the frailty under examination. Furthermore, both at T0 and T1 questionnaires will be completed and carried out clinical evaluations (anamnesis, physical examination, tests for the study of the autonomic nervous system, bio-impedance test, evaluation/estimate of maximal oxygen consumption, ECG).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 22, 2023

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

March 1, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 18, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2023

Completed
Last Updated

April 18, 2023

Status Verified

April 1, 2023

Enrollment Period

4 months

First QC Date

March 1, 2023

Last Update Submit

April 3, 2023

Conditions

Keywords

chronic inflammationphysical exerciselifestyleprevention

Outcome Measures

Primary Outcomes (1)

  • Change in maximal oxygen consumption (VO2 max)

    The maximum or optimum rate at which the heart, lungs, and muscles can effectively use oxygen during exercise, used as a way of measuring a person's individual aerobic capacity.

    Change from baseline VO2 max at six months

Study Arms (1)

Physical exercise prescription

EXPERIMENTAL

Prescription of a personalized exercise program, which will define modalities, intensity, duration, frequency and progression of the exercise. For each subject, at baseline and after 6 months, biological samples will be collected (blood, urine, saliva and nasal swab)

Other: Physical exercise

Interventions

Personalized exercise program, with defined modalities, intensity, duration, frequency and progression of the exercise.

Physical exercise prescription

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being an employee of UMilan of both sexes and of any age (18-70 years);
  • For the 100 chosen subjects identified for Phase 2: declare that they do not carry out physical activities at a competitive level and that you are committed about improving your own lifestyle.

You may not qualify if:

  • Previous myocardial infarction
  • Autoimmune diseases
  • Neurodegenerative pathologies
  • Psychiatric pathologies
  • Cardiac arrhythmias
  • Chronic obstructive pulmonary disease
  • osteo-muscular problems that prevent the execution of physical activity;
  • oncological pathologies in the last 3 years that have required chemotherapy or immunotherapy;
  • pregnancy/nursing/intention to become pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Milan

Milan, 20122, Italy

Location

Related Publications (1)

  • Bianchi F, Biganzoli EM, Bollati V, Clerici M, Lucini D, Mando C, Rota F; HEBE Consortium. HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol. PLoS One. 2024 Apr 30;19(4):e0300011. doi: 10.1371/journal.pone.0300011. eCollection 2024.

Related Links

MeSH Terms

Conditions

Motor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Elia M Biganzoli, PhD

    University of Milan

    STUDY DIRECTOR
  • Daniela Lucini, PhD

    University of Milan

    PRINCIPAL INVESTIGATOR
  • Valentina Bollati, PhD

    University of Milan

    PRINCIPAL INVESTIGATOR
  • Francesca Bianchi, PhD

    University of Milan

    PRINCIPAL INVESTIGATOR
  • Chiara Mandò, PhD

    University of Milan

    PRINCIPAL INVESTIGATOR
  • Mario Clerici, PhD

    University of Milan

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Participants will be assessed before and after the intervention with physical exercise and personalized lifestyle advice.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor of Medical Statistics

Study Record Dates

First Submitted

March 1, 2023

First Posted

April 18, 2023

Study Start

November 8, 2022

Primary Completion

February 22, 2023

Study Completion

July 20, 2023

Last Updated

April 18, 2023

Record last verified: 2023-04

Locations